Vault-13

Knoll Capital Management, LLC

MIAMI, FL · CIK 1325083 · 13F filing filed 2023-11-14

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$96.3m reported value +18.0% vs Q2 2023
37positions
70.5%in top 10
12 new 8 added 1 reduced 1 sold out vs Q2 2023

Holdings, Q3 2023

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 ALDEYRA THERAPEUTICS INC COM ALDX ALDX 3,031,915 $20.3m21.02% 21.02% AddedShares held: Q4 2022 1.9m, Q1 2023 2.1m, Q2 2023 3.0m, Q3 2023 3.0m +16.2k +16,247 0.5%
2 APPLIED THERAPEUTICS INC COM APLT APLT 5,162,088 $12.9m13.34% 13.34% AddedShares held: Q4 2022 2.5m, Q1 2023 3.5m, Q2 2023 3.5m, Q3 2023 5.2m +1.7m +1,712,088 49.6%
3 BIOHAVEN PHARMACTL HLDG CO L COM BHVN BHVN 490,422 $12.8m13.24% 13.24% AddedShares held: Q4 2022 450.4k, Q1 2023 450.4k, Q2 2023 450.4k, Q3 2023 490.4k +40.0k +40,000 8.9%
4 AVADEL PHARMACEUTICALS PLC SPONSORED ADR SPONSORED ADR 600,000 $6.2m6.41% 6.41% AddedShares held: Q4 2022 150.0k, Q1 2023 0, Q2 2023 500.0k, Q3 2023 600.0k +100.0k +100,000 20.0%
5 HOOKIPA PHARMA INC COM COM 5,517,385 $3.4m3.53% 3.53% UnchangedShares held: Q4 2022 50.0k, Q1 2023 300.0k, Q2 2023 5.5m, Q3 2023 5.5m
6 VERONA PHARMA PLC SPONSORED ADS VRNA VRNA 200,000 $3.3m3.38% 3.38% UnchangedShares held: Q4 2022 95.4k, Q1 2023 200.0k, Q2 2023 200.0k, Q3 2023 200.0k
7 SEABRIDGE GOLD INC COM COM 246,597 $2.6m2.70% 2.70% AddedShares held: Q4 2022 41.0k, Q1 2023 80.0k, Q2 2023 80.0k, Q3 2023 246.6k +166.6k +166,597 208.2%
8 VANECK ETF TRUST GOLD MINERS ETF GDX GDX 91,850 $2.5m2.57% 2.57% UnchangedShares held: Q4 2022 91.8k, Q1 2023 91.8k, Q2 2023 91.8k, Q3 2023 91.8k
9 GLOBAL X FDS GLOBAL X SILVER SIL SIL 89,700 $2.1m2.23% 2.23% UnchangedShares held: Q4 2022 89.7k, Q1 2023 89.7k, Q2 2023 89.7k, Q3 2023 89.7k
10 KINROSS GOLD CORP COM KGC KGC 440,000 $2.0m2.08% 2.08% NewShares held: Q4 2022 0, Q1 2023 0, Q2 2023 0, Q3 2023 440.0k
11 FRANCO NEV CORP COM FNV FNV 14,500 $1.9m2.01% 2.01% AddedShares held: Q4 2022 0, Q1 2023 7.0k, Q2 2023 7.0k, Q3 2023 14.5k +7.5k +7,500 107.1%
12 WHEATON PRECIOUS METALS CORP COM WPM WPM 47,500 $1.9m2.00% 2.00% NewShares held: Q4 2022 0, Q1 2023 0, Q2 2023 0, Q3 2023 47.5k
13 AGNICO EAGLE MINES LTD COM AEM AEM 40,000 $1.8m1.89% 1.89% NewShares held: Q4 2022 0, Q1 2023 0, Q2 2023 0, Q3 2023 40.0k
14 SILVERCREST METALS INC COM SIL SIL 410,000 $1.8m1.88% 1.88% AddedShares held: Q4 2022 0, Q1 2023 170.0k, Q2 2023 170.0k, Q3 2023 410.0k +240.0k +240,000 141.2%
15 ENTERA BIO LTD SHS ENTX ENTX 2,484,275 $1.8m1.87% 1.87% UnchangedShares held: Q4 2022 2.5m, Q1 2023 2.5m, Q2 2023 2.5m, Q3 2023 2.5m
16 EQUINOX GOLD CORP COM EQX EQX 420,929 $1.8m1.85% 1.85% NewShares held: Q4 2022 0, Q1 2023 0, Q2 2023 0, Q3 2023 420.9k
17 VANECK ETF TRUST JUNIOR GOLD MINE GDXJ GDXJ 53,150 $1.7m1.78% 1.78% UnchangedShares held: Q4 2022 53.1k, Q1 2023 53.1k, Q2 2023 53.1k, Q3 2023 53.1k
18 MAG SILVER CORP COM MAG MAG 160,000 $1.7m1.72% 1.72% NewShares held: Q4 2022 0, Q1 2023 0, Q2 2023 0, Q3 2023 160.0k
19 BOOZ ALLEN HAMILTON HLDG COR CL A BAH BAH 13,000 $1.4m1.47% 1.47% UnchangedShares held: Q4 2022 13.0k, Q1 2023 13.0k, Q2 2023 13.0k, Q3 2023 13.0k
20 FIRST MAJESTIC SILVER CORP COM AG AG 275,000 $1.4m1.46% 1.46% NewShares held: Q4 2022 0, Q1 2023 0, Q2 2023 0, Q3 2023 275.0k
21 VISA INC COM CL A V V 4,850 $1.1m1.16% 1.16% UnchangedShares held: Q4 2022 4.8k, Q1 2023 4.8k, Q2 2023 4.8k, Q3 2023 4.8k
22 THERMO FISHER SCIENTIFIC INC COM TMO TMO 2,100 $1.1m1.10% 1.10% UnchangedShares held: Q4 2022 2.1k, Q1 2023 2.1k, Q2 2023 2.1k, Q3 2023 2.1k
23 CVS HEALTH CORP COM CVS CVS 14,500 $1.0m1.05% 1.05% UnchangedShares held: Q4 2022 14.5k, Q1 2023 14.5k, Q2 2023 14.5k, Q3 2023 14.5k
24 ALTRIA GROUP INC COM MO MO 22,700 $954.5k0.99% 0.99% UnchangedShares held: Q4 2022 22.7k, Q1 2023 22.7k, Q2 2023 22.7k, Q3 2023 22.7k
25 NORTHROP GRUMMAN CORP COM NOC NOC 2,165 $953.0k0.99% 0.99% UnchangedShares held: Q4 2022 0, Q1 2023 2.2k, Q2 2023 2.2k, Q3 2023 2.2k
26 ALAMOS GOLD INC NEW COM CL A AGI AGI 80,000 $903.2k0.94% 0.94% NewShares held: Q4 2022 0, Q1 2023 0, Q2 2023 0, Q3 2023 80.0k
27 LOCKHEED MARTIN CORP COM LMT LMT 2,150 $879.3k0.91% 0.91% NewShares held: Q4 2022 0, Q1 2023 0, Q2 2023 0, Q3 2023 2.1k
28 ROYAL GOLD INC COM RGLD RGLD 7,550 $802.8k0.83% 0.83% NewShares held: Q4 2022 0, Q1 2023 0, Q2 2023 0, Q3 2023 7.5k
29 PAN AMERN SILVER CORP COM PAAS PAAS 54,085 $783.1k0.81% 0.81% NewShares held: Q4 2022 0, Q1 2023 0, Q2 2023 0, Q3 2023 54.1k
30 OSISKO GOLD ROYALTIES LTD COM COM 400,000 $732.0k0.76% 0.76% UnchangedShares held: Q4 2022 235.0k, Q1 2023 400.0k, Q2 2023 400.0k, Q3 2023 400.0k
31 AMYLYX PHARMACEUTICALS INC COM AMLX AMLX 24,772 $453.6k0.47% 0.47% NewShares held: Q4 2022 0, Q1 2023 0, Q2 2023 0, Q3 2023 24.8k
32 Orgenesis, Inc. COM COM 634,738 $393.5k0.41% 0.41% UnchangedShares held: Q4 2022 634.7k, Q1 2023 634.7k, Q2 2023 634.7k, Q3 2023 634.7k
33 OMEGA THERAPEUTICS INC COMMON STOCK COMMON STOCK 173,010 $372.0k0.39% 0.39% UnchangedShares held: Q4 2022 0, Q1 2023 173.0k, Q2 2023 173.0k, Q3 2023 173.0k
34 OPUS GENETICS INC COM IRD IRD 100,000 $335.0k0.35% 0.35% UnchangedShares held: Q4 2022 0, Q1 2023 100.0k, Q2 2023 100.0k, Q3 2023 100.0k
35 NEW PAC METALS CORP COM NEWP NEWP 131,654 $233.0k0.24% 0.24% NewShares held: Q4 2022 0, Q1 2023 0, Q2 2023 0, Q3 2023 131.7k
36 BIOXCEL THERAPEUTICS INC COM COM 60,000 $151.8k0.16% 0.16% AddedShares held: Q4 2022 0, Q1 2023 0, Q2 2023 30.0k, Q3 2023 60.0k +30.0k +30,000 100.0%
37 OCULAR THERAPEUTIX INC COM OCUL OCUL 400 $1.3k0.00% 0.00% ReducedShares held: Q4 2022 0, Q1 2023 200.0k, Q2 2023 200.0k, Q3 2023 400 -199.6k -199,600 -99.8%

Sold out since Q2 2023

SecurityTickerShares held beforeValue then
ALTIMMUNE INC ALT ALT 173,864 $613.7k173.9k shares

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
ELICIO THERAPEUTICS INC ELTX · 13G · filed 2026-07-08 ELTX 5.3%≈ $4.7m +0.1 pts 13G 2026-07-08